Article
Massively parallel characterization of CYP2C9 variant enzyme activity and abundance
2021-03-14
Abstract excerpt
<h4>ABSTRACT</h4> CYP2C9 encodes a cytochrome P450 enzyme responsible for metabolizing up to 15% of small molecule drugs, and CYP2C9 variants can alter the safety and efficacy of these therapeutics. In particular, the anti-coagulant warfarin is prescribed to over 15 million people annually and polymorphisms in CYP2C9 can affect patient response leading to an increased risk of hemorrhage. We developed Click-seq,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- edf44e66-420c-5498-98cc-44c23de4c1e1
- DOI
- 10.1101/2021.03.12.435209
